Skip to main content
. 2021 Sep 3;11:17644. doi: 10.1038/s41598-021-96631-x

Figure 1.

Figure 1

Changes (individuals, mean ± SD) in plasma complement component 1q (C1q) (a), apelin (b) and adropin (c) concentrations before (pre) and after (post) 12 weeks of descending (DSW) and ascending stair walking (ASW) interventions. *Significant change (p ≤ 0.05) compared to the baseline (pre) level in each group; ns: no significant difference (p ≥ 0.05) from the baseline (pre) level; #Significant difference (p ≤ 0.05) compared to the post-intervention level in the ASW group.